Secondary Prevention of Esophageal Squamous Cell Carcinoma in Areas Where Smoking, Alcohol, and Betel Quid Chewing are Prevalent

Journal of the Formosan Medical Association

Volumn 109, Issue 6, 2010, Pages 408-421

  Chung, Chen Shuan ^a,b   Lee, Yi Chia ^a   Wang, Cheng Ping ^a,c   Ko, Jenq Yuh ^c   Wang, Wen Lun ^a,d   Wu, Ming Shiang ^a   Wang, Hsiu Po ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

areca nut; betel quid; cancer prevention; esophageal cancer; image enhanced endoscopy

Indexed keywords

ALCOHOL CONSUMPTION; BETEL NUT; CANCER DIAGNOSIS; CANCER INVASION; CANCER PREVENTION; CANCER STAGING; CANCER SUSCEPTIBILITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; MASTICATION; PREDICTION; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING;

ADENOCARCINOMA; ALCOHOL DRINKING; ARECA; ASIA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; MASTICATION; PACIFIC ISLANDS; PREVALENCE; RISK FACTORS; SECONDARY PREVENTION; SMOKING;

EID: 77953664497     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60072-1     Document Type: Review

References (91)

1. Shaheen N.J., and Richter J.E. Barrett's oesophagus. Lancet 373 (2009) 850-861
2. Lee Y.C., Yen A.M., Tai J.J., et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 58 (2009) 174-181
3. Bolye P., and Levin B. World cancer report (2008), International Agency for Research on Cancer, Lyon
4. National Department of Health, Taiwan, Republic of China. Cancer Registry Annual Report. 1972-2009.
5. Smith M., Zhou M., Whitlock G., et al. Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122 (2008) 1604-1610
6. Yamaji T., Inoue M., Sasazuki S., et al. Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study. Int J Cancer 123 (2008) 1935-1940
7. Sjöberg T., Rodríguez L.G., and Lindblad M. Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study. Clin Gastroenterol Hepatol 5 (2007) 1160-1166
8. Sadeghi S., Bain C.J., Pandeya N., et al. Aspirin, non-steroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol Biomarkers Prev 17 (2008) 1169-1178
9. Pottern L.M., Morris L.E., Blot W.J., et al. Esophageal cancer among black men in Washington, D.C. 1. Alcohol, tobacco, and other risk factors. J Natl Cancer Inst 67 (1981) 777-783
10. Yu M.C., Garabrant D.H., Peters J.M., et al. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res 48 (1988) 3843-3848
11. De Stefani E., Muñoz N., Estève J., et al. Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay. Cancer Res 50 (1990) 426-431
12. Graham S., Marshall J., Haughev B., et al. Nutritional epidemiology of cancer of the esophagus. Am J Epidemiol 131 (1990) 454-467
13. Franceschi S., Talamini R., Barra S., et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50 (1990) 6502-6507
14. Sankaranarayanan R., Duffy S.W., Padmakumary G., et al. Risk factors for cancer of the oesophagus in Kerala, India. Znt J Cancer 49 (1991) 485-489
15. Cheng K.K., Day N.E., Duffy S.W., et al. Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet 339 (1992) 1314-1318
16. Gao Y.T., McLaughlin J.K., Blot W.J., et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 58 (1994) 192-196
17. Castelletto R., Castellsague X., Muñoz N., et al. Alcohol, tobacco, diet, mate drinking, and esophageal cancer in Argentina. Cancer Epidemiol Biomarkers Prev 3 (1994) 557-564
18. Vaughan T.L., Davis S., Kristal A., et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4 (1995) 85-92
19. Castellsague X., Munoz N., De Stefani E., et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 82 (1999) 657-664
20. Lagergren J., Bergstrom R., Lindgren A., et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85 (2000) 340-346
21. Wu M.T., Lee Y.C., Chen C.J., et al. Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer 85 (2001) 658-660
22. Gallus S., Altieri A., Bosetti C., et al. Cigarette tar yield and risk of upper digestive tract cancers: case-control studies from Italy and Switzerland. Ann Oncol 14 (2003) 209-213
23. Lee C.H., Lee J.M., Wu D.C., et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 113 (2005) 475-482
24. Garavello W., Negri E., Talamini R., et al. Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev 14 (2005) 1390-1393
25. Wu I.C., Lu C.Y., Kuo F.C., et al. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest 36 (2006) 236-241
26. Hashibe M., Boffetta P., Janout V., et al. Esophageal cancer in Central and Eastern Europe: tobacco and alcohol. Int J Cancer 120 (2007) 1518-1522
27. Wang J.M., Xu B., Rao J.Y., et al. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol 19 (2007) 171-176
28. Nasrollahzadeh D., Kamangar F., Aghcheli K., et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 98 (2008) 1857-1863
29. Pandeya N., Williams G., Green A.C., et al. Australian Cancer Study. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 136 (2009) 1215-1224 e1-2.
30. Yen A.M., Chen S.C., and Chen T.H. Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quid. Oral Oncol 43 (2007) 634-638
31. Yen A.M., Chen L.S., Chiu Y.H., et al. A prospective community-population-registry-based cohort study of the association between betel-quid chewing and cardiovascular disease in men in Taiwan. Am J Clin Nutr 87 (2008) 70-78
32. Yen A.M., Chiu Y.H., Chen L.S., et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 83 (2006) 1153-1160
33. Wu G.H., Boucher B.J., Chiu Y.H., et al. Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections. Public Health Nutr 12 (2009) 129-135
34. Chen T.H., Chiu Y.H., and Boucher B.J. Transgenerational effects of betel-quid chewing on the development of the metabolic syndrome in the Keelung Community-based Integrated Screening Program. Am J Clin Nutr 83 (2006) 688-692
35. Goan Y.G., Chang H.C., Hsu H.K., et al. Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese. Cancer Sci 96 (2005) 758-765
36. Li Y., Ma J., Guo Q., et al. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus 22 (2009) 664-667
37. Langevin S.M., Lin D., Matsuo K., et al. Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett 184 (2009) 73-80
38. Upadhyay R., Jain M., Kumar S., et al. Association of inter-leukin-6 (<174G > C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol 128 (2008) 199-204
39. Lee C.H., Lee J.M., Wu D.C., et al. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 122 (2008) 1347-1356
40. Yokoyama A., and Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Alcohol 35 (2005) 175-185
41. Hashibe M., Mckay J.D., Curado M.P., et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet 40 (2008) 707-709
42. Chuang S.C., Scelo G., Tonita J.M., et al. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 123 (2008) 2390-2396
43. Wang C.P., Lee Y.C., Yang T.L., et al. Application of unsedated transnasal esophagogastroduodenoscopy in the diagnosis of hypopharyngeal cancer. Head Neck 31 (2009) 153-157
44. Wang C.P., Lee Y.C., and Lou P.J. Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head and neck cancer. Oral Oncol 45 (2009) 615-620
45. Yokoyama A., Yokoyama T., Muramatsu T., et al. Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men. Carcinogenesis 24 (2003) 1773-1778
46. Chang H.W., Ling G.S., Wei W.I., et al. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 101 (2004) 125-132
47. Abbaszadegan M.R., Raziee H.R., Ghafarzadegan K., et al. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer 36 (2005) 47-54
48. Wei W.Q., Abnet C.C., Lu N., et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 54 (2005) 759-763
49. Fagundes R.B., Melo C.R., Pütten A., et al. p53 immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?. Cancer Detect Prev 29 (2005) 227-232
50. Fang M.Z., Jin Z., Wang Y., et al. Promoter hypermethylation and inactivation of O(6)- methylguanine-DNA methyl-transferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 26 (2005) 615-622
51. Roth M.J., Abnet C.C., Hu N., et al. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep 15 (2006) 1591-1597
52. Anupam K., Tusharkant C., Gupta S.D., et al. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 12 (2006) 6041-6045
53. Guo M., Ren J., House M.G., et al. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res 12 (2006) 4515-4522
54. Kaneko K., Katagiri1 A., Konishi K., et al. Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. Br J Cancer 96 (2007) 492-498
55. Ishii T., Murakami J., Notohara K., et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut 56 (2007) 13-19
56. Zhou Y.Z., Fang X.Q., Li H., et al. Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors. Chin Med J 120 (2007) 1216-1219
57. He S., Guo G.M., Liu F.X., et al. Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 134 (2008) 307-315
58. Yokoyama T., Yokoyama A., Kumagai Y., et al. Health risk appraisal models for mass screening of esophageal cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 17 (2008) 2846-2854
59. Adams L., Roth M.J., Abnet C.C., et al. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res 1 (2008) 357-361
60. Kamangar F., Diaw L., Wei W.Q., et al. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 124 (2009) 456-460
61. Yokoyama A., Kumagai Y., Yokoyama T., et al. Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18 (2009) 651-655
62. Varadarajulu S., Eloubeidi M.A., Patel R.S., et al. The yield and the predictors of esophageal pathology when upper endoscopy is used for the initial evaluation of dysphagia. Gastrointest Endosc 61 (2005) 809-811
63. Yokoyama T., Yokoyama A., Kato H., et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12 (2003) 1227-1233
64. Iijima K., Koike T., Abe Y., et al. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 102 (2007) 1603-1609
65. Ren J.S., Kamangar F., Qiao Y.L., et al. Serum pepsinogens and risk of gastric and esophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 58 (2009) 636-642
66. Cheung W.Y., and Liu G. Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am 38 (2009) 75-91
67. Hibi K., Taguchi M., Nakayama H., et al. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7 (2001) 3135-3138
68. Oka D., Yamashita S., Tomioka T., et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 115 (2009) 3412-3426
69. Shiozaki H., Tahara H., Kobayashi K., et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 66 (1990) 2068-2071
70. Okumura T., Aruga H., Inohara H., et al. Endoscopic examination of the upper gastrointestinal tract for the presence of second primary cancers in head and neck cancer patients. Acta Otolaryngol (Stockh) 501 (1993) 103-106
71. Yokoyama A., Ohmori T., Makuuchi H., et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer 15 (1995) 928-934
72. Meyer V., Burtin P., Bour B., et al. Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improved videoendoscopy?. Gastrointest Endosc 45 (1997) 480-484
73. Dawsey S.M., Fleischer D.E., Wang G.Q., et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 83 (1998) 220-231
74. Freitag C.P.F., Barros S.G.S., Krudel C.D.P., et al. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in Southern Brazil. Dis Esophagus 12 (1999) 191-195
75. Tincani A.J., Brandalise N., Altemani A., et al. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer. Head Neck 22 (2000) 170-174
76. Mayinger B., Horner P., Jordan M., et al. Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer. Gastrointest Endosc 54 (2001) 195-201
77. Muto M., Hironaka S., Nakane M., et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 56 (2002) 517-521
78. Yoshida T., Inoue H., Usui S., et al. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 59 (2004) 288-295
79. Uedo N., Iishi H., Tatsuta M., et al. A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest Endosc 62 (2005) 521-528
80. Hashimoto C.L., Iriya K., Baba E.R., et al. Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 100 (2005) 275-282
81. Dubuc J., Legoux J.L., Winnock M., et al. Endoscopic screening for esophageal squamous cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 38 (2006) 690-695
82. Möschler O., Spahn T.W., Bisping C.M., et al. Chromo-endoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion 73 (2006) 160-166
83. Lee Y.C., Wang C.P., Chen C.C., et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope. Gastrointest Endosc 69 (2009) 408-417
84. Yoshida Y., Goda K., Tajiri H., et al. Assessment of novel endoscopic techniques for visualizing superficial esophageal squamous cell carcinoma: autofluorescence and narrowband imaging. Dis Esophagus 22 (2009) 439-446
85. Lee C.T., Chang C.Y., Tai C.M., et al. Endoscopic screening of esophageal cancer in patients with head and neck cancers: a prospective study by comparison of narrow-band-imaging with high-magnification and conventional endoscopy. Gastrointest Endosc 69 (2009) AB347
86. Takubo K., Aida J., Sawabe M., et al. Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology 51 (2007) 733-742
87. Katada C., Muto M., Manabe T., et al. Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc 61 (2005) 219-225
88. Muto M., Katada C., Sano Y., et al. Narrow band imaging: a new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clin Gastroenterol Hepatol 3 (2005) S16-S20
89. Curvers W.L., Singh R., Song L.M., et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using highresolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 57 (2008) 167-172
90. Somerville M., Garside R., Pitt M., et al. Surveillance of Barrett's oesophagus: is it worthwhile?. Eur J Cancer 44 (2008) 588-599
91. Barbiere J.M., and Lyratzopoulos G. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review. Gastroenterology 137 (2009) 1869-1876